Paper Details

  1. Home
  2. Paper Details

[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96].

Author: BerentsenS, BrinchL, DahlI M, LamvikJ, LyB, NesthusI, ShammasF V, SjoM, TangenJ M

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated the treatment, clinical course, and outcome of patients with chronic myeloid leukemia in a defined region of Norway over a six-year period. The study found that median survival for all patients was 36 months, with better survival rates for younger patients and those who received allogeneic stem cell transplantation.
Paper Details　
Original Abstract of the Article :
The aim of the present investigation was to obtain information about treatment, clinical course and outcome for all patients with chronic myeloid leukaemia through a six-year period in a defined part of Norway. A total number of 141 patients fulfilled the diagnostic criteria. This is equivalent to 0...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/10380587

データ提供：米国国立医学図書館（NLM）

Chronic Myeloid Leukemia: A Journey through Treatment and Survival

Chronic myeloid leukemia (CML), a type of blood cancer, requires a multifaceted approach to treatment. This study examines the treatment, clinical course, and survival outcomes of CML patients in a defined region of Norway. It's like navigating a desert landscape, understanding the different challenges and strategies involved in managing this complex disease.

A Mosaic of Treatment Approaches: CML Management

The study reveals that CML patients received a range of treatments, including hydroxyurea, interferon, and allogeneic stem cell transplantation. It's like a mosaic of different approaches, each offering its own advantages and disadvantages. The study highlights the importance of tailoring treatment plans to individual patient needs and characteristics. The study also found that survival rates varied significantly based on age and treatment approach, emphasizing the need for continued research to optimize treatment strategies and improve outcomes.

A Quest for Improved Outcomes

This study underscores the challenges and complexities of managing CML. The findings highlight the need for ongoing research into new treatments and strategies to improve survival rates and quality of life for CML patients. It's a reminder that the desert of cancer research is vast and complex, but with continued exploration and innovation, we can find new oases of hope and progress.

Dr. Camel's Conclusion

This study provides a glimpse into the realities of chronic myeloid leukemia (CML) treatment and survival. The study highlights the importance of individualized treatment plans and emphasizes the need for continued research into new and more effective therapies. It's a reminder that the desert of CML research is vast and challenging, but with persistent effort and innovation, we can find pathways to better treatments and improve the lives of those affected.

Date :
  1. Date Completed 1999-07-07
  2. Date Revised 2008-07-16
Further Info :

Pubmed ID

10380587

DOI: Digital Object Identifier

10380587

Related Literature

Article Analysis
・Effective treatment of chronic myeloid leukemia
SNS
PICO Info
in preparation
Languages

Norwegian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.